Phase II Study of Concurrent Continuous Temozolomide (TMZ) and Tamoxifen (TMX) for Recurrent Malignant Astrocytic Gliomas

被引：0

作者：

Alexander M. Spence

Richard A. Peterson

Jeffrey D. Scharnhorst

Daniel L. Silbergeld

Robert C. Rostomily

机构：

[1] University of Washington,Department of Neurology, 356465

[2] University of Washington School of Medicine,Departments of Neurology and Neurological Surgery

来源：

Journal of Neuro-Oncology | 2004年 / 70卷

关键词：

anaplastic astrocytoma; glioblastoma multiforme; phase II; Tamoxifen; Temozolomide;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Purpose and background: The aim of this study was to assess the frequency of response and toxicity in adults with recurrent anaplastic astrocytoma (AA) or glioblastoma multiforme (GM) treated with concurrent continuous TMZ and TMX.

引用

页码：91 / 95

页数：4

共 50 条

[41] PHASE-II STUDY OF SPIROHYDANTOIN MUSTARD FOR THE TREATMENT OF RECURRENT MALIGNANT GLIOMAS
PRADOS, M
RODRIGUEZ, L
SEAGER, M
SILVER, P
LEVIN, V
CANCER TREATMENT REPORTS, 1987, 71 (11): : 1105 - 1106
[42] PHASE II STUDY OF ARSENIC TRIOXIDE AND TEMOZOLOMIDE IN COMBINATION WITH RADIATION THERAPY IN PATIENTS WITH MALIGNANT GLIOMAS
Kumthekar, P.
Grimm, S. A.
Marymont, M.
Mehta, M.
Chandler, J.
Muro, K.
Jovanovic, B.
Helenowski, I.
McCarthy, K.
Raizer, J.
NEURO-ONCOLOGY, 2014, 16
[43] A PHASE 1 STUDY EVALUATING ABT-414 WITH TEMOZOLOMIDE (TMZ) OR CONCURRENT RADIOTHERAPY (RT) AND TMZ IN GLIOBLASTOMA (GBM)
Gan, Hui K.
Fichtel, Lisa
Lassman, Andrew B.
Merrell, Ryan
van den Bent, Martin
Kumthekar, Priya
Scott, Andrew M.
Pedersen, Michelle
Gomez, Erica
Fischer, JuDee
Ames, William
Xiong, Hao
Dudley, Matt
Munasinghe, Wijith
Roberts-Rapp, Lisa
Ansell, Peter
Holen, Kyle
Reardon, David A.
NEURO-ONCOLOGY, 2014, 16
[44] Phase I study of vorinostat (suberoylanilide hydroxamic acid) in combination with temozolomide (TMZ) in patients with malignant gliomas (NABTC 04-03)
Wen, P. Y.
Puduvalli, V.
Kuhn, J.
Reid, J.
Cloughesy, T.
Yung, W. A.
Chang, S. M.
Robbins, H. I.
McGovern, R.
Ames, M.
Prados, M. D.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[45] Phase II trial of 4-hourly temozolomide (TMZ) in advanced malignant melanoma (MM)
Arance, A
Middleton, M
Thatcher, N
EUROPEAN JOURNAL OF CANCER, 1999, 35 : S371 - S371
[46] TEMOBIC: A ANOCEF phase II study of BCNU and temozolomide (TMZ) combination prior to radiotherapy (RT) in anaplasic oligodendroglial gliomas (AOG).
Chinot, O. L.
Hoang-Xuan, K.
Fabbro, M.
Taillandier, L.
Honnorat, J.
Barrie, M.
Sanson, M.
Kerr, C.
Beauchesne, P.
Cartalat-Carel, S.
Autran, D.
Loundou, A.
Guillevin, R.
Mokhtari, K.
Figarella-Branger, D.
Delattre, J.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[47] Recurrent malignant gliomas: Comparison of different phase II studies
Soffietti, R
Ruda, R
Bradac, GB
Vasario, E
Schiffer, D
NEUROLOGY, 1996, 46 (02) : 66004 - 66004
[48] A PHASE II STUDY OF LAPATINIB AND DOSE-DENSE TEMOZOLOMIDE (TMZ) FOR ADULTS WITH RECURRENT EPENDYMOMA: A CERN CLINICAL TRIAL
Gilbert, Mark
Yuan, Ying
Wani, Khalida
Wu, Jimin
Omuro, Antonio
Lieberman, Frank
Robins, H. Ian
Gerstner, Elizabeth
Wu, Jing
Wen, Patrick
Mikkelsen, Tom
Armstrong, Terri
Aldape, Ken
NEURO-ONCOLOGY, 2014, 16
[49] A phase I/II study of temozolomide (TMZ) and the farnesyltransferase inhibitor (FTI), tipifarnib (Zarnestra, ZAR) in recurrent glioblastoma (GBM)
Gilbert, Mark
Gaupp, Patricia
Ictech, Sandra
Hess, Ken
Groves, Morris
Levin, Victor
Conrad, Charles
Puduvalli, Vinay
Colman, Howard
De Groot, John
Hsu, Sigmond
De Porre, Peter
Yung, W. K. Alfred
NEURO-ONCOLOGY, 2007, 9 (04) : 524 - 524
[50] Phase I trial combining SCH 66336 to temozolomide (TMZ) for patients with grade 3 or 4 malignant gliomas (MG)
Desjardins, A.
Reardon, D. A.
Gururangan, S.
Peters, K.
Threatt, S.
Friedman, A.
Friedman, H.
Vredenburgh, J.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)

← 1 2 3 4 5 →